Hormone Replacement Therapy

Low-dose transdermal estrogen a viable short-term HRT for menopausal women

Published in Women's Health Weekly, May 13th, 2004

Low-dose transdermal hormone replacement therapy (HRT) remains a viable short-term alternative for women to treat debilitating menopausal symptoms, offer lipid protection, and preserve bone health, despite the negative news about oral HRT effects from the Women's Health Initiative (WHI), according to a recently-published literature review.

In the April 2004 Journal of Reproductive Medicine, Mary Jane Minkin, MD, of the Yale University School of Medicine, discussed what she found in her search of peer-reviewed medical studies.

"There is a lot to consider when interpreting the WHI results. The fact is that millions of women still suffer from the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2004-05-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry